Detalhe da pesquisa
1.
Comparison of the resonance sonorheometry based Quantra® system with rotational thromboelastometry ROTEM® sigma in cardiac surgery - a prospective observational study.
BMC Anesthesiol
; 21(1): 260, 2021 10 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34711167
2.
t(11;14)-positive mantle cell lymphomas lacking cyclin D1 (CCND1) immunostaining because of a CCND1 mutation or exclusive expression of the CCND1b isoform.
Haematologica
; 103(9): e432-e435, 2018 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-29773591
3.
Nivolumab and ipilimumab in recurrent or refractory cancer of unknown primary: a phase II trial.
Nat Commun
; 14(1): 6761, 2023 10 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-37875494
4.
Nivolumab Switch Maintenance Therapy After Tyrosine Kinase Inhibitor Induction in Metastatic Renal Cell Carcinoma: A Randomized Clinical Trial by the Interdisciplinary Working Group on Renal Tumors of the German Cancer Society (NIVOSWITCH; AIO-NZK-0116ass).
Eur Urol
; 84(6): 571-578, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-37758574
5.
Surgical Treatment of Cerebellar Metastases: Survival Benefits, Complications and Timing Issues.
Cancers (Basel)
; 13(21)2021 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-34771427
6.
Durvalumab after definitive chemoradiotherapy in locally advanced NSCLC: Data of the German EAP.
Data Brief
; 34: 106556, 2021 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-33364266
7.
Durvalumab after definitive chemoradiotherapy in locally advanced unresectable non-small cell lung cancer (NSCLC): Real-world data on survival and safety from the German expanded-access program (EAP).
Lung Cancer
; 150: 114-122, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33126091
8.
A novel nonobese diabetic/severe combined immunodeficient xenograft model for chronic lymphocytic leukemia reflects important clinical characteristics of the disease.
Cancer Res
; 67(18): 8653-61, 2007 Sep 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-17875705
9.
The clinical significance of soluble human leukocyte antigen class-I, ICTP, and RANKL molecules in multiple myeloma patients.
Hum Immunol
; 69(2): 79-87, 2008 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-18361931
10.
Long-term results of a phase-I/II study of sequential high-dose chemotherapy with autologous stem cell transplantation in the initial treatment of aggressive non-Hodgkin's lymphoma.
Tumori
; 93(5): 409-16, 2007.
Artigo
em Inglês
| MEDLINE | ID: mdl-18038870
11.
Immune parameters in multiple myeloma patients: influence of treatment and correlation with opportunistic infections.
Leuk Lymphoma
; 47(8): 1570-82, 2006 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-16966269
12.
Prognostic relevance of soluble human leukocyte antigen-G and total human leukocyte antigen class I molecules in lung cancer patients.
Hum Immunol
; 71(5): 489-95, 2010 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-20156510
13.
Pemetrexed with or without matuzumab as second-line treatment for patients with stage IIIB/IV non-small cell lung cancer.
J Thorac Oncol
; 5(12): 1977-85, 2010 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-20978446
14.
Soluble MICA as an independent prognostic factor for the overall survival and progression-free survival of multiple myeloma patients.
Clin Immunol
; 123(1): 114-20, 2007 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-17218152
15.
Clinical validation of a digital transcutaneous PCO2/SpO2 ear sensor in adult patients after cardiac surgery.
J Clin Monit Comput
; 21(5): 303-9, 2007 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-17701383
16.
In vitro dendritic cell generation and lymphocyte subsets in myeloma patients: influence of thalidomide and high-dose chemotherapy treatment.
Cancer Immunol Immunother
; 54(5): 506-12, 2005 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-15750834
17.
Thalidomide in combination with dexamethasone for pretreated patients with multiple myeloma: serum level of soluble interleukin-2 receptor as a predictive factor for response rate and for survival.
Ann Hematol
; 84(9): 594-600, 2005 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-15744524